Vitamin K for Heart Disease
(Nutricog Trial)

Recruiting in Palo Alto (17 mi)

Overseen ByGuylaine Ferland, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Montreal Heart Institute

Trial Summary

What is the purpose of this trial?The purpose of this pilot study is to obtain a preliminary assessment of the effect of VK supplementation on cognitive performance and vascular function in adults with stable Coronary Heart Disease (CHD)

Eligibility Criteria

This trial is for adults with stable Coronary Heart Disease (CHD) who are interested in exploring the potential cognitive and vascular benefits of Vitamin K supplementation.

Inclusion Criteria

I do not take vitamin K supplements or cognitive aids.

I am 60 years old or older.

My heart disease condition is stable.

+4 more

Exclusion Criteria

I have a condition that affects how my body absorbs nutrients.

I have not had a recent heart attack or heart surgery in the last 3 months.

Unable to read the informed consent form or unable to understand the oral explanations provided by the assessor

+6 more

Participant Groups

The NutriCog study is testing whether taking Vitamin K supplements can improve brain function and blood vessel health in people with CHD, compared to a placebo (a substance with no active drug).

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Dietary Supplement: Vitamin KExperimental Treatment1 Intervention

Participants receive 0.5 mg/day phylloquinone orally for 12 weeks

Group II: Dietary Supplement: PlaceboPlacebo Group1 Intervention

Participants receive daily placebo for 12 weeks